Premium
P2‐160: 31 P magnetic resonance spectroscopy on normal aging human brain at 3.0T
Author(s) -
Chiu Pui Wai,
Chi Andrew,
Law Kin,
Shiu Joseph,
Kwan Kwong,
Chuen Raymond,
Chang Chung,
Chu Leung Wing,
Fung Mak Henry Ka
Publication year - 2015
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2015.06.699
Subject(s) - phosphocreatine , nuclear magnetic resonance , voxel , nuclear medicine , in vivo magnetic resonance spectroscopy , nuclear magnetic resonance spectroscopy , magnetic resonance imaging , flip angle , alzheimer's disease neuroimaging initiative , metabolite , chemistry , posterior cingulate , medicine , alzheimer's disease , physics , functional magnetic resonance imaging , energy metabolism , radiology , disease
patients with confirmed diagnosis of AD (11.8% increase V1⁄449, p<.05; Figure 2) and those with confirmed diagnosis of non-AD (13.6% increase; V1⁄40, p<.05; Figure 3). 243 PET scans were evaluated by two nuclear medicine physicians, who disagreed on 32 cases (rate of concordance: 86.8%). Conclusions:Data are in line with previous reports. Based on preliminary results, amyloid PET with 18F-Florbetapir has a significant impact on diagnosis and diagnostic confidence of dementia experts.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom